Aprea Therapeutics, Inc. (APRE)
Cost of Revenue
$5.43K
TTM · Period ending: · USD
APRE Cost of Revenue
Latest reported$5.43Kperiod ending
Latest reported$5.43Kperiod ending
APRE TTM Cost of Revenue ($0.00 → $5.43K)
TTM cost of revenue
High-resolution chart · PNG
APRE cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 5,428 | |
| 1,917,641 | |
| 4,395,279 | |
| 6,754,365 | |
| 9,600,764 | |
| 10,246,230 | |
| 9,363,537 | |
| 9,050,139 | |
| 8,326,343 | |
| 7,971,321 | |
| 7,627,490 | |
| 6,113,208 | |
| 5,108,181 | |
| 9,717,133 | |
| 8,460,591 | |
| 7,929,185 | |
| 6,811,609 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |